BioPharm International-12-01-2014

Industry professionals share the ups and downs of working in the biopharma industry.

Operational changes at FDA and CDER aim to improve global market monitoring.

Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.

MedicalRF.com/Science Photo Library-ANDRZEJ WOJCICKI/Henrik Jonsson/Stocktrek Images; Dan Ward

Biopharma employees report gains in compensation and job satisfaction, as industry growth continues.

The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.

The author proposes a quality management system that uses the power of executive management to promote a positive quality culture.

Performing degradation studies is the best strategy to evaluate toxicity risk.

Tosoh Bioscience’s CaPure-HA hydroxyapatite chromatography resin is designed for the purification of monoclonal antibodies, polyclonal antibodies, and antibody fragments, and the separation of antibody isoforms and isozymes.

Click the title above to open the BioPharm International December 2014 issue in an interactive PDF format.